GSK to invest $1.2bn in infectious diseases R&D in lower-income countries
The company has established a non-commercial Global Health Unit to meet the goals.
Europe Understanding the Attractiveness for Investments
Non-stop investment from CMOs and US Government into continuous manufacturing
FDI in pharmaceuticals: The state of play
Pfizer plans $120m investment for Covid-19 oral drug manufacturing in US
Holistic thinking is prescribed for investors on World Health Day 2022
Lilly suspends investments in Russia amid Ukraine crisis
Pfizer plans to halt additional investments in Russia amid Ukraine crisis
The UK to provide $347m investment for healthcare research
